Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Targovax ASA
Scientific Title
A Non-Randomised Open-Label Phase Ib Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Recurrent Oncogenic RAS Exon 2 Mutant Rectal Cancer